Jardiance 25 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJLN5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,640
Award facts
- Contract value 100% obligated
- $18,639.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,639.72 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed price contract, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical vendor for federal military and veteran healthcare systems, with an extensive portfolio covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's SPE2DX prime contract vehicle functions as a comprehensive global pharmaceutical support mechanism enabling supply of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Jardiance, an antidiabetic medication, aligns with AmerisourceBergen's demonstrated capability to supply diabetes medications and other specialty pharmaceuticals across multiple therapeutic domains through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FJLN5?
SPE2DB25FJLN5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FJLN5 worth?
The government has obligated $18,640 on SPE2DB25FJLN5.
Is contract SPE2DB25FJLN5 an order under another contract?
Yes. SPE2DB25FJLN5 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJLN5 competed?
The extent of competition for SPE2DB25FJLN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award